FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to a molecule binding dipeptidyl peptidase-3 (hereinafter – DPP3). The specified DPP3-binding molecule shows affinity with DPP3 in such a way that affinity constant is at least 10-7 M-1, while the specified DPP3-binding molecule blocks DPP3 bioactivity by at least 10%.
EFFECT: invention is effective for the prevention or treatment of diseases or acute conditions in a patient, while the specified disease or acute condition is related to oxidative stress.
11 cl, 6 dwg, 7 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
| VARIANT CD3 BINDING DOMAINS AND THEIR USE IN COMBINATION THERAPY FOR TREATMENT OF DISEASES | 2019 |
|
RU2810222C2 |
| MOLECULES BINDING TO 4-1BB | 2011 |
|
RU2551963C2 |
| OX40 BINDING POLYPEPTIDES AND THEIR USE | 2019 |
|
RU2802070C2 |
| BINDING MOLECULES INDUCING CELLULAR ACTIVATION | 2019 |
|
RU2770620C1 |
| SPECIFIC BINDING MOLECULES | 2020 |
|
RU2825837C2 |
| NEW PSMA-BINDING ANTIBODY AND ITS APPLICATIONS | 2017 |
|
RU2762704C2 |
| ANTIBODIES BINDING TO PD-1 AND THEIR APPLICATIONS | 2019 |
|
RU2773758C2 |
| ILT7 BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2756109C2 |
| ANTIBODIES BINDING TO CD3 | 2019 |
|
RU2810924C2 |
